Bristol Myers Squibb Announces Phase 3 EXCALIBER-RRMM Study Evaluating Iberdomide in Combination with Standard Therapies ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...

The award recognizes the work educators at Washington Elementary have done over several years to embed health and wellness ...

Researchers report a materials breakthrough enabling a new wave of nanodrug applications, from delivery to diagnostics and ...

Akeso Inc. (9926.HK) is excited to announce that the Late-Breaking Abstract (LBA) from the registrational Phase III clinical ...

Swiss pharmaceutical and diagnostics giant Roche Holding has finally released some positive news about its oral breast cancer ...

Phoenix Sky Harbor remains high in J.D. Power's airport satisfaction survey for 2025, one year after a 10-spot jump. Here's ...

Rise in alcohol deaths Deadly alcohol use on the rise. The rates of alcohol induced deaths have nearly doubled since 1999. Although overall rates for men are greater, females 25-34 showed a shocking ...

HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of ...

Idaho State University appears to be getting more serious about buying the Idaho College of Osteopathic Medicine in Meridian ...

The teacher says my son sometimes has trouble focusing, but it’s only in one class, and when he describes the class, it ...

Government scientists say infection rates from drug-resistant “nightmare bacteria” have been increasing dramatically ...